Taiwan · Delayed Price · Currency is TWD Synmosa Biopharma Statistics
Total Valuation
TPEX:4114 has a market cap or net worth of TWD 15.91 billion. The enterprise value is 17.68 billion.
| Market Cap | 15.91B |
| Enterprise Value | 17.68B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Jul 17, 2026 |
Share Statistics
TPEX:4114 has 541.12 million shares outstanding. The number of shares has increased by 5.16% in one year.
| Current Share Class | 541.12M |
| Shares Outstanding | 541.12M |
| Shares Change (YoY) | +5.16% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 9.46% |
| Owned by Institutions (%) | 4.89% |
| Float | 413.35M |
Valuation Ratios
The trailing PE ratio is 19.24.
| PE Ratio | 19.24 |
| Forward PE | n/a |
| PS Ratio | 2.38 |
| PB Ratio | 1.61 |
| P/TBV Ratio | 1.98 |
| P/FCF Ratio | 80.49 |
| P/OCF Ratio | 41.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.13, with an EV/FCF ratio of 89.44.
| EV / Earnings | 21.37 |
| EV / Sales | 2.65 |
| EV / EBITDA | 17.13 |
| EV / EBIT | 25.86 |
| EV / FCF | 89.44 |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.34.
| Current Ratio | 2.03 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 3.13 |
| Debt / FCF | 16.86 |
| Interest Coverage | 11.20 |
Financial Efficiency
Return on equity (ROE) is 5.91% and return on invested capital (ROIC) is 5.25%.
| Return on Equity (ROE) | 5.91% |
| Return on Assets (ROA) | 3.05% |
| Return on Invested Capital (ROIC) | 5.25% |
| Return on Capital Employed (ROCE) | 6.06% |
| Weighted Average Cost of Capital (WACC) | 3.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.46 |
| Inventory Turnover | 1.73 |
Taxes
In the past 12 months, TPEX:4114 has paid 197.44 million in taxes.
| Income Tax | 197.44M |
| Effective Tax Rate | 25.37% |
Stock Price Statistics
The stock price has decreased by -8.51% in the last 52 weeks. The beta is -0.02, so TPEX:4114's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -8.51% |
| 50-Day Moving Average | 29.64 |
| 200-Day Moving Average | 29.37 |
| Relative Strength Index (RSI) | 43.86 |
| Average Volume (20 Days) | 516,876 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4114 had revenue of TWD 6.68 billion and earned 827.17 million in profits. Earnings per share was 1.53.
| Revenue | 6.68B |
| Gross Profit | 2.75B |
| Operating Income | 714.96M |
| Pretax Income | 778.35M |
| Net Income | 827.17M |
| EBITDA | 1.04B |
| EBIT | 714.96M |
| Earnings Per Share (EPS) | 1.53 |
Balance Sheet
The company has 2.78 billion in cash and 3.33 billion in debt, with a net cash position of -551.87 million or -1.02 per share.
| Cash & Cash Equivalents | 2.78B |
| Total Debt | 3.33B |
| Net Cash | -551.87M |
| Net Cash Per Share | -1.02 |
| Equity (Book Value) | 9.87B |
| Book Value Per Share | 15.98 |
| Working Capital | 3.58B |
Cash Flow
In the last 12 months, operating cash flow was 384.05 million and capital expenditures -186.41 million, giving a free cash flow of 197.64 million.
| Operating Cash Flow | 384.05M |
| Capital Expenditures | -186.41M |
| Depreciation & Amortization | 320.06M |
| Net Borrowing | 660.09M |
| Free Cash Flow | 197.64M |
| FCF Per Share | 0.37 |
Margins
Gross margin is 41.18%, with operating and profit margins of 10.70% and 12.38%.
| Gross Margin | 41.18% |
| Operating Margin | 10.70% |
| Pretax Margin | 11.65% |
| Profit Margin | 12.38% |
| EBITDA Margin | 15.50% |
| EBIT Margin | 10.70% |
| FCF Margin | 2.96% |
Dividends & Yields
This stock pays an annual dividend of 0.79, which amounts to a dividend yield of 2.68%.
| Dividend Per Share | 0.79 |
| Dividend Yield | 2.68% |
| Dividend Growth (YoY) | 52.92% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 32.96% |
| FCF Payout Ratio | 232.27% |
| Buyback Yield | -5.16% |
| Shareholder Yield | -2.49% |
| Earnings Yield | 5.20% |
| FCF Yield | 1.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 17, 2026. It was a forward split with a ratio of 1.079847978.
| Last Split Date | Jul 17, 2026 |
| Split Type | Forward |
| Split Ratio | 1.079847978 |
Scores
TPEX:4114 has an Altman Z-Score of 2.78 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.78 |
| Piotroski F-Score | 3 |